X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cipla with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs ADCOCK INGRAM (S. Africa) - Comparison Results

CIPLA    Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CIPLA   ADCOCK INGRAM
EQUITY SHARE DATA
    CIPLA
Mar-18
ADCOCK INGRAM
Jun-14
CIPLA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs663363-   
Low Rs479262-   
Sales per share (Unadj.) Rs189.0107.8-  
Earnings per share (Unadj.) Rs17.6-27.2-  
Cash flow per share (Unadj.) Rs34.0-22.5-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs176.784.6-  
Shares outstanding (eoy) m805.12168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.02.9 104.4%   
Avg P/E ratio x32.5-11.5 -282.6%  
P/CF ratio (eoy) x16.8-13.9 -121.1%  
Price / Book Value ratio x3.23.7 87.6%  
Dividend payout %17.10-   
Avg Mkt Cap Rs m459,72452,659 873.0%   
No. of employees `00023.64.3 550.0%   
Total wages/salary Rs m26,9013,305 813.9%   
Avg. sales/employee Rs Th6,446.14,239.5 152.1%   
Avg. wages/employee Rs Th1,139.4769.9 148.0%   
Avg. net profit/employee Rs Th600.0-1,068.3 -56.2%   
INCOME DATA
Net Sales Rs m152,19318,200 836.2%  
Other income Rs m3,577127 2,806.2%   
Total revenues Rs m155,76918,327 849.9%   
Gross profit Rs m28,264-3,154 -896.1%  
Depreciation Rs m13,228786 1,684.0%   
Interest Rs m1,142493 231.7%   
Profit before tax Rs m17,470-4,305 -405.8%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m-280-   
Extraordinary Inc (Exp) Rs m-7750-   
Tax Rs m2,501269 929.8%   
Profit after tax Rs m14,166-4,586 -308.9%  
Gross profit margin %18.6-17.3 -107.2%  
Effective tax rate %14.3-6.2 -229.1%   
Net profit margin %9.3-25.2 -36.9%  
BALANCE SHEET DATA
Current assets Rs m108,14113,330 811.3%   
Current liabilities Rs m38,3227,500 511.0%   
Net working cap to sales %45.932.0 143.2%  
Current ratio x2.81.8 158.8%  
Inventory Days Days97111 87.5%  
Debtors Days Days74124 60.0%  
Net fixed assets Rs m109,4117,770 1,408.1%   
Share capital Rs m1,61085 1,905.6%   
"Free" reserves Rs m140,6820-   
Net worth Rs m142,29214,285 996.1%   
Long term debt Rs m36,6215,020 729.5%   
Total assets Rs m228,60626,986 847.1%  
Interest coverage x16.3-7.7 -210.7%   
Debt to equity ratio x0.30.4 73.2%  
Sales to assets ratio x0.70.7 98.7%   
Return on assets %6.7-15.2 -44.1%  
Return on equity %10.0-32.1 -31.0%  
Return on capital %10.0-19.8 -50.3%  
Exports to sales %32.80-   
Imports to sales %00-   
Net fx Rs m30,6580-   
CASH FLOW
From Operations Rs m14,6281,554 941.6%  
From Investments Rs m-8,540-477 1,790.4%  
From Financial Activity Rs m-3,8554,556 -84.6%  
Net Cashflow Rs m2,4315,633 43.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5 Rs / ZAR

Compare CIPLA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare CIPLA With: ELDER PHARMA  ALEMBIC LTD  UNICHEM LAB  FRESENIUS KABI ONCO.  SANOFI INDIA  



Today's Market

From Urjit Patel to Shaktikanta Das; What Lies Ahead?(Podcast)

The week gone by saw Sensex plunge from 700 points to rise by over 600 points. With a volatile and eventful week, it was a challenge keeping up with the news every day.

Related Views On News

CIPLA Announces Quarterly Results (2QFY19); Net Profit Down 15.8% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, CIPLA has posted a net profit of Rs 4 bn (down 15.8% YoY). Sales on the other hand came in at Rs 40 bn (down 1.7% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (1QFY19); Net Profit Up 4.7% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, CIPLA has posted a net profit of Rs 4 bn (up 4.7% YoY). Sales on the other hand came in at Rs 39 bn (up 11.7% YoY). Read on for a complete analysis of CIPLA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Dec 14, 2018 (Close)

TRACK CIPLA

COMPARE CIPLA WITH

MARKET STATS